Lan Winnie1, Yi-Hsuan Kao2, Chien-Chang Liao3,4,5, Takahiro Tamura6, Ming-Long Chang7, Kun-Yi Hsieh8. 1. Department of General Medicine, Taipei Medical University Shuang-Ho Hospital, New Taipei City, Taiwan. 2. Department of General Medicine, Mackay Memorial Hospital, Taipei, Taiwan. 3. Department of Anesthesiology, Taipei Medical University Hospital, Taipei 11031, Taiwan. 4. School of Chinese Medicine, College of Chinese Medicine, Taiwan Medical University, Taichung, Taiwan. 5. Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. 6. Department of Anesthesiology, Nagoya University Graduate Institute of Medicine, Nagoya, Japan. 7. Department of Emergency Medicine, Taipei Medical University Hospital, Taipei 11031, Taiwan. 8. Emergency Department, Taipei Municipal Wanfang Hospital, Taipei 116, Taiwan.
Abstract
Background: The optimal dose and concentration of analgesic efficacy of ropivacaine (RPV) and bupivacaine (BPV) for postoperative pain relief in paediatric abdominal surgery patients is still unclear. Therefore, this meta-analysis compared the efficacy of these analgesics, their administered modes (ultrasound-guided RSB versus LAI) for postoperative pain relief, and side effects. Methods: Three databases, PubMed, Embase, and Cochrane Database of Systematic Reviews, were exhaustively searched with predefined keywords. Eight randomized clinical trials and retrospective studies were selected. Analgesic effect, postoperative pain score, level of side effect, applied dose, and concentration of drug were analysed. Results: Drug dose ranged from 0.5-2.5 mL/kg of 0.2 to 0.5% concentrations. Male participant for RSB and LAI treatment groups varied from 40-62% and 25-83%, respectively. Mean age of RSB and LAI groups ranged from 3.8-11.65 years and 4.3-11.27 years, respectively. Our meta-analysis revealed that RSB could reduce total opioid use postoperatively (WMD = -0.02, 95% CI: -0.02, -0.02), with I 2 value of 15%. We found that the RPV (0.25%, 2.5 ml/kg) was optimal in suppressing the pain. Its lower concentration (0.2%) was ineffective, whereas higher one (0.375%) seems to increase risk of systemic toxicity. Similarly, BPV (0.25%, 2.5 mg/kg) efficaciously reduced the pain score, while its lower concentration was ineffective. The combined postoperative pain score in the RPV-treated group was found to be significantly reduced (p < 0.01) with I 2 value of 85% indicating high heterogeneity. Conclusion: Both RPV and BPV were significantly effective in reducing postoperative pain score. It appears that RSB could be a preferred choice to deliver analgesia, due to reduced opiate dose requirement and improved clinical safety without significant postoperative adverse events.
Background: The optimal dose and concentration of analgesic efficacy of ropivacaine (RPV) and bupivacaine (BPV) for postoperative pain relief in paediatric abdominal surgery patients is still unclear. Therefore, this meta-analysis compared the efficacy of these analgesics, their administered modes (ultrasound-guided RSB versus LAI) for postoperative pain relief, and side effects. Methods: Three databases, PubMed, Embase, and Cochrane Database of Systematic Reviews, were exhaustively searched with predefined keywords. Eight randomized clinical trials and retrospective studies were selected. Analgesic effect, postoperative pain score, level of side effect, applied dose, and concentration of drug were analysed. Results: Drug dose ranged from 0.5-2.5 mL/kg of 0.2 to 0.5% concentrations. Male participant for RSB and LAI treatment groups varied from 40-62% and 25-83%, respectively. Mean age of RSB and LAI groups ranged from 3.8-11.65 years and 4.3-11.27 years, respectively. Our meta-analysis revealed that RSB could reduce total opioid use postoperatively (WMD = -0.02, 95% CI: -0.02, -0.02), with I 2 value of 15%. We found that the RPV (0.25%, 2.5 ml/kg) was optimal in suppressing the pain. Its lower concentration (0.2%) was ineffective, whereas higher one (0.375%) seems to increase risk of systemic toxicity. Similarly, BPV (0.25%, 2.5 mg/kg) efficaciously reduced the pain score, while its lower concentration was ineffective. The combined postoperative pain score in the RPV-treated group was found to be significantly reduced (p < 0.01) with I 2 value of 85% indicating high heterogeneity. Conclusion: Both RPV and BPV were significantly effective in reducing postoperative pain score. It appears that RSB could be a preferred choice to deliver analgesia, due to reduced opiate dose requirement and improved clinical safety without significant postoperative adverse events.
Authors: Sean H Flack; Lizabeth D Martin; Benjamin J Walker; Adrian T Bosenberg; Laurilyn D Helmers; Adam B Goldin; Charles M Haberkern Journal: Paediatr Anaesth Date: 2014-05-22 Impact factor: 2.556
Authors: Cristen N Litz; Sandra M Farach; Allison M Fernandez; Richard Elliott; Jenny Dolan; Nikhil Patel; Lillian Zamora; Paul M Colombani; Nebbie E Walford; Ernest K Amankwah; Christopher W Snyder; Paul D Danielson; Nicole M Chandler Journal: J Pediatr Surg Date: 2017-03-16 Impact factor: 2.545
Authors: Bernhard M Graf; Ingo Abraham; Nicole Eberbach; Gudrun Kunst; David F Stowe; Eike Martin Journal: Anesthesiology Date: 2002-06 Impact factor: 7.892
Authors: R Scott Dingeman; Lindsay M Barus; Hyun Kee Chung; David J Clendenin; Christopher S Lee; Sarah Tracy; Victor M Johnson; Kate V Dennett; David Zurakowski; Catherine Chen Journal: JAMA Surg Date: 2013-08 Impact factor: 14.766
Authors: Uzma Shamim Seth; Sughra Perveen; Tanweer Ahmed; Mohammad Taha Kamal; Jehangir Ali Soomro; Munira Murtaza Khomusi; Maha Kamal Journal: Cureus Date: 2022-04-13